Nippon Shinyaku Co., Ltd. (OTCMKTS:NPNKF – Get Free Report) was the recipient of a significant increase in short interest in the month of April. As of April 30th, there was short interest totaling 116,473 shares, an increase of 89.1% from the April 15th total of 61,597 shares. Based on an average daily volume of 55 shares, the short-interest ratio is presently 2,117.7 days.
Nippon Shinyaku Stock Performance
NPNKF remained flat at $31.40 during midday trading on Tuesday. Nippon Shinyaku has a 12-month low of $31.40 and a 12-month high of $32.00. The firm’s fifty day moving average is $32.35 and its two-hundred day moving average is $32.73.
About Nippon Shinyaku
Nippon Shinyaku Co, Ltd. operates as a research-driven pharmaceutical company headquartered in Kyoto, Japan. It specializes in the discovery, development, manufacture and marketing of therapeutic drugs across multiple therapeutic areas, including urology, hematology, oncology and internal medicine. The company’s business model integrates in-house research capabilities with strategic collaborations to bring novel small-molecule and biologic products to market.
Established in 1909 by entrepreneur Yorisuke Tsuji, Nippon Shinyaku has evolved from a domestic manufacturer into a global healthcare enterprise.
See Also
- Five stocks we like better than Nippon Shinyaku
- The $132 Billion Infrastructure Pivot You Might Have Missed
- Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings
- Rewiring AI: NextEra Energy Sparks a Mega Merger
- Flipping the Switch: Is Ford the Next Big Energy Stock?
Receive News & Ratings for Nippon Shinyaku Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nippon Shinyaku and related companies with MarketBeat.com's FREE daily email newsletter.
